Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
dc.contributor.author | Tomlinson, OW | |
dc.contributor.author | Markham, L | |
dc.contributor.author | Wollerton, RL | |
dc.contributor.author | Knight, BA | |
dc.contributor.author | Duckworth, A | |
dc.contributor.author | Gibbons, MA | |
dc.contributor.author | Scotton, CJ | |
dc.contributor.author | Williams, CA | |
dc.date.accessioned | 2022-12-23T16:06:59Z | |
dc.date.issued | 2022-12-22 | |
dc.date.updated | 2022-12-23T15:48:40Z | |
dc.description.abstract | Background: Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO2peak), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to be fully characterised, and this study flls this evidence gap. Methods: Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month window. Technical standards from the European Respiratory Society established validity, and repeatability was determined using mean change, intraclass correlation coefcient and typical error. Results: Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO2, the primary criteria for establishing a maximal efort. The majority of participants otherwise presented with secondary criteria of respiratory exchange ratios in excess of 1.05, and maximal heart rates in excess of their predicted values. Repeatability analyses identifed that the typical error (expressed as percent of coefcient of variation) was 20% over 3-months in those reaching volitional exhaustion. Conclusion: This work has, for the frst time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verifcation criteria, and generated novel repeatability data that will prove useful in the assessment of disease progression, and future evaluation of therapeutic regimens where VO2peak is used as an outcome measure. | en_GB |
dc.description.sponsorship | Royal Devon and Exeter NHS Foundation Trust Hospital | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.description.sponsorship | GW4 BioMed Medical Research Council | en_GB |
dc.identifier.citation | Vol. 22, No. 1, article 485 | en_GB |
dc.identifier.doi | https://doi.org/10.1186/s12890-022-02289-0 | |
dc.identifier.uri | http://hdl.handle.net/10871/132080 | |
dc.identifier | ORCID: 0000-0003-4063-7682 (Tomlinson, Owen W) | |
dc.language.iso | en | en_GB |
dc.publisher | BMC | en_GB |
dc.rights | © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | en_GB |
dc.subject | Aerobic fitness | en_GB |
dc.subject | Clinical physiology | en_GB |
dc.subject | Maximal exercise | en_GB |
dc.subject | Pulmonary disease | en_GB |
dc.title | Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2022-12-23T16:06:59Z | |
exeter.article-number | 485 | |
dc.description | This is the final version. Available from BMC via the DOI in this record. | en_GB |
dc.description | Availability of data and materials: Data cannot be deposited in open access repositories for ethical reasons. Please contact the corresponding author (CAW) to discuss data access. | en_GB |
dc.identifier.eissn | 1471-2466 | |
dc.identifier.journal | BMC Pulmonary Medicine | en_GB |
dc.relation.ispartof | BMC Pulmonary Medicine, 22(1) | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2022-12-15 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2022-12-22 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2022-12-23T15:59:02Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2022-12-23T16:07:51Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2022-12-22 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.